ESGO 2027 Congress

February 25 - 27, 2027

London, United Kingdom

The ESGO 2027 Congress in London opens in 

Join ESGO 2027 Congress, 
the largest European gathering in gynaecological cancers!

The 28th Congress of the European Society of Gynaecological Oncology will bring together over 4,000 attendees from around the world for gathering of learning, networking, and sharing the latest developments in the field of gynaecological cancers — all with the goal of enhancing your knowledge, accelerating your skills and advancing the field.

ESGO 2027 will be a celebration of discovery and late-breaking research, new guidelinespractical demonstrations, and exclusive live surgery transmissions you don't want to miss.

homepage

Important Deadlines

  • October 30, 2026
    Abstract submission deadline
  • December 17, 2026
    Early registration deadline
  • January 15, 2027
    LBA submission deadline*
  • February 18, 2027
    Standard registration deadline

3800+
Attendees

100+
International Speakers

100+
Countries

1500+
Abstracts

200+
Lectures

Eriksson

Prof Ane Gerda Zahl Eriksson, Norway
Scientific Programme Chair

“As Scientific Programme Chair of ESGO 2027, I promise a programme filled with cutting-edge science, surgical developments and stimulating peer-to-peer interactions bringing you the latest within gynae-oncology. I look forward to welcoming you to ESGO 2027 and to a world full of science!”

Ledermann2

Prof Jonathan Ledermann, UK
Congress President

“I'm pleased to be hosting the 2027 ESGO Congress which will be held in London. Women's health – and particularly women's cancers – are very much in the spotlight, and the Congress comes at an important time where we can reflect on the scientific developments and care of women with gynaecological cancers and create a lasting legacy.”

Sehouli

Prof Jalid Sehouli, Germany
ESGO President

“With a commitment to scientific excellence, patient-centred care, and social responsibility, our annual Congress serves as a vital forum for professionals dedicated to promoting the highest quality of care and the best prevention of gynaecological cancers. We invite you to join us in London to advance research and education and improve the health and well-being of women globally.”